Microsoft Aims to Make Windows an AI-Powered Operating System

Microsoft has announced the release of a new lineup of laptops, Copilot+, equipped with powerful artificial intelligence chips for performing complex tasks such as real-time translation and image generation. Additionally, Windows 11 will introduce new generative AI-based features, including Recall, which will help users find previously accessed applications, files, and other content on their computers….

Read More

In honor of the anniversary of Diablo IV, players will receive free items, and the game will host the “Goblin March” event

Blizzard has announced that in honor of the upcoming first anniversary of Diablo IV, which will take place on June 6, a special celebratory event called the “Goblin March” will be held in the game. The festive event will begin on June 6 and will offer players the following exciting activities: – Until June 13,…

Read More

The CRISPR technology has partially restored vision to people with inherited blindness.

Scientists have presented the results of the first phase of clinical trials involving 14 people with inherited blindness, specifically Leber congenital amaurosis. Significant improvements in vision parameters have been observed with the application of CRISPR gene editing technology. Leber congenital amaurosis is characterized by a mutation in the CEP290 gene, resulting in severe vision loss,…

Read More

“Democracy Prevails”: Sony Agrees to Players’ Demands, Removes Mandatory PSN Requirement in Helldivers 2

For several consecutive days, player outrage has been brewing over the recent update in Helldivers 2. Due to Sony’s directive, the developers of the popular cooperative shooter implemented mandatory linking of PSN accounts in the game. This decision did not sit well with PC gamers, who have already written over 300,000 negative reviews on Steam….

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More